| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 2.35e-06 | 38 | 206 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.76e-06 | 118 | 206 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH4 MYH9 WAPL MYO10 SMC1A TOR4A SRCAP TRIP13 MYO3A ACSF3 DDX24 DHX40 DDX55 DNAH7 DNAH1 MYH14 MACF1 ATP1B2 | 2.14e-05 | 614 | 206 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | calcium ion binding | CRACR2B EFEMP1 SPOCK3 BAIAP3 COMP SYT3 PCDHGA10 PCDHGA2 ANXA11 PCDHA10 ADAMTS13 DNAH7 CRB1 TGM2 P4HTM OCM MACF1 EFCC1 LTBP3 RAPGEF2 | 1.01e-04 | 749 | 206 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | actin filament binding | 1.29e-04 | 227 | 206 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB CCND3 NEK11 NLK | 2.31e-04 | 446 | 206 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 2.33e-04 | 54 | 206 | 5 | GO:0030159 | |
| GeneOntologyMolecularFunction | plus-end directed microfilament motor activity | 3.16e-04 | 3 | 206 | 2 | GO:0060002 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 3.88e-04 | 129 | 206 | 7 | GO:0035591 | |
| GeneOntologyMolecularFunction | calmodulin binding | 6.63e-04 | 230 | 206 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MYH4 MYH9 MYLK STUB1 MYO10 CEP295NL MYO3A ANLN HOOK2 JAKMIP1 MYO18B GNB1 GNB3 RAB3B SYNM SYNE1 KLC4 INF2 MYH14 CTNNA3 MACF1 TOR1AIP1 | 1.01e-03 | 1099 | 206 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.04e-03 | 5 | 206 | 2 | GO:0030156 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MYLK SPEG DGKQ RPS6KC1 MYO3A TAOK3 BMPR2 EFEMP1 GRK3 WNK3 IP6K2 RPS6KA4 CDC42BPA CDC42BPB CCND3 NEK11 NLK | 1.13e-03 | 709 | 206 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 EFEMP1 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB CCND3 NEK11 NLK | 1.47e-03 | 600 | 206 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH4 MYH9 MYLK MYO10 MYO3A ANLN MYO18B SYNE1 INF2 MYH14 CTNNA3 MACF1 | 1.47e-03 | 479 | 206 | 13 | GO:0003779 |
| GeneOntologyCellularComponent | myosin complex | 1.74e-06 | 59 | 205 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 3.91e-06 | 25 | 205 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH4 MYH9 MYLK MYO10 KEAP1 MYO3A ANLN NTN1 MYO18B CDC42BPA ANKRD26 BCAR1 CDC42BPB OCM INF2 MYH14 MACF1 AKAP13 | 4.31e-06 | 576 | 205 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | myosin II complex | 7.07e-06 | 28 | 205 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 3.16e-05 | 7 | 205 | 3 | GO:0005826 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 MYH4 MYH9 CDK2AP2 STUB1 KEAP1 MYO3A GRK3 HOOK2 JAKMIP1 MYO18B SYNM KRT33A KRT82 SYNE1 KLC4 DNAH7 DNAH1 JPH1 ADAMTS10 OCM INF2 MYH14 MACF1 AKAP13 TEKT4 LZTS2 | 3.59e-05 | 1179 | 205 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 MYH4 MYH9 CDK2AP2 STUB1 KEAP1 MYO3A GRK3 HOOK2 JAKMIP1 MYO18B SYNM KRT33A KRT82 SYNE1 KLC4 DNAH7 DNAH1 JPH1 ADAMTS10 OCM INF2 MYH14 MACF1 AKAP13 TEKT4 LZTS2 | 4.03e-05 | 1187 | 205 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | extracellular matrix | EMILIN3 EFEMP1 ADAMTS9 SPOCK3 GLG1 ADAMTS20 NTN1 COL6A2 ZAN COMP ANXA11 ADAMTS13 TF TGFB2 ADAMTS10 TGM2 LTBP3 MUC2 | 8.71e-05 | 656 | 205 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | EMILIN3 EFEMP1 ADAMTS9 SPOCK3 GLG1 ADAMTS20 NTN1 COL6A2 ZAN COMP ANXA11 ADAMTS13 TF TGFB2 ADAMTS10 TGM2 LTBP3 MUC2 | 9.05e-05 | 658 | 205 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | myosin II filament | 2.85e-04 | 3 | 205 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | contractile ring | 3.12e-04 | 14 | 205 | 3 | GO:0070938 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 3.71e-04 | 35 | 205 | 4 | GO:0005834 | |
| GeneOntologyCellularComponent | tumor necrosis factor receptor superfamily complex | 5.67e-04 | 4 | 205 | 2 | GO:0002947 | |
| GeneOntologyCellularComponent | GTPase complex | 6.85e-04 | 41 | 205 | 4 | GO:1905360 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | EMILIN3 EFEMP1 ADAMTS9 ADAMTS20 NTN1 COL6A2 COMP ANXA11 TF TGFB2 ADAMTS10 TGM2 LTBP3 MUC2 | 7.78e-04 | 530 | 205 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | cell division site | 1.14e-03 | 80 | 205 | 5 | GO:0032153 | |
| Domain | Guanine_nucleotide-bd_bsu | 6.20e-08 | 5 | 199 | 4 | IPR016346 | |
| Domain | Myosin_head_motor_dom | 1.34e-07 | 38 | 199 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.34e-07 | 38 | 199 | 7 | PS51456 | |
| Domain | Myosin_head | 1.34e-07 | 38 | 199 | 7 | PF00063 | |
| Domain | MYSc | 1.34e-07 | 38 | 199 | 7 | SM00242 | |
| Domain | IQ | 8.64e-07 | 71 | 199 | 8 | PF00612 | |
| Domain | Myosin-like_IQ_dom | 1.34e-06 | 19 | 199 | 5 | IPR027401 | |
| Domain | - | 1.34e-06 | 19 | 199 | 5 | 4.10.270.10 | |
| Domain | IQ | 2.39e-06 | 81 | 199 | 8 | SM00015 | |
| Domain | Gprotein_B | 2.50e-06 | 10 | 199 | 4 | IPR001632 | |
| Domain | IQ_motif_EF-hand-BS | 5.30e-06 | 90 | 199 | 8 | IPR000048 | |
| Domain | IQ | 6.77e-06 | 93 | 199 | 8 | PS50096 | |
| Domain | Myosin_N | 1.56e-05 | 15 | 199 | 4 | PF02736 | |
| Domain | Myosin_N | 1.56e-05 | 15 | 199 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 3.40e-05 | 18 | 199 | 4 | PF01576 | |
| Domain | Myosin_tail | 3.40e-05 | 18 | 199 | 4 | IPR002928 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.12e-04 | 24 | 199 | 4 | IPR013273 | |
| Domain | Pept_M12B_GON-ADAMTSs | 1.13e-04 | 2 | 199 | 2 | IPR012314 | |
| Domain | GON | 1.13e-04 | 2 | 199 | 2 | PS51046 | |
| Domain | GON | 1.13e-04 | 2 | 199 | 2 | PF08685 | |
| Domain | KELK | 1.13e-04 | 2 | 199 | 2 | IPR031597 | |
| Domain | KELK | 1.13e-04 | 2 | 199 | 2 | PF15796 | |
| Domain | Ser/Thr_kinase_AS | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 1.24e-04 | 357 | 199 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 1.42e-04 | 362 | 199 | 13 | PS00108 |
| Domain | Pkinase | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 2.34e-04 | 381 | 199 | 13 | PF00069 |
| Domain | G_IRG_dom | 3.36e-04 | 3 | 199 | 2 | IPR030385 | |
| Domain | Transferrin | 3.36e-04 | 3 | 199 | 2 | PF00405 | |
| Domain | Transferrin | 3.36e-04 | 3 | 199 | 2 | IPR016357 | |
| Domain | TRANSFERRIN_LIKE_4 | 3.36e-04 | 3 | 199 | 2 | PS51408 | |
| Domain | TRANSFERRIN_LIKE_1 | 3.36e-04 | 3 | 199 | 2 | PS00205 | |
| Domain | TRANSFERRIN_LIKE_2 | 3.36e-04 | 3 | 199 | 2 | PS00206 | |
| Domain | TRANSFERRIN_LIKE_3 | 3.36e-04 | 3 | 199 | 2 | PS00207 | |
| Domain | Transferrin_Fe_BS | 3.36e-04 | 3 | 199 | 2 | IPR018195 | |
| Domain | TFIID-31 | 3.36e-04 | 3 | 199 | 2 | IPR003162 | |
| Domain | TR_FER | 3.36e-04 | 3 | 199 | 2 | SM00094 | |
| Domain | Transferrin-like_dom | 3.36e-04 | 3 | 199 | 2 | IPR001156 | |
| Domain | TFIID-31kDa | 3.36e-04 | 3 | 199 | 2 | PF02291 | |
| Domain | G_IRG | 3.36e-04 | 3 | 199 | 2 | PS51716 | |
| Domain | Death | 4.02e-04 | 33 | 199 | 4 | PF00531 | |
| Domain | S_TKc | MYLK SPEG RPS6KC1 MYO3A TAOK3 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 4.89e-04 | 359 | 199 | 12 | SM00220 |
| Domain | TSP_1 | 5.56e-04 | 63 | 199 | 5 | PF00090 | |
| Domain | VWF_type-D | 6.02e-04 | 16 | 199 | 3 | IPR001846 | |
| Domain | VWFD | 6.02e-04 | 16 | 199 | 3 | PS51233 | |
| Domain | VWD | 6.02e-04 | 16 | 199 | 3 | SM00216 | |
| Domain | VWD | 6.02e-04 | 16 | 199 | 3 | PF00094 | |
| Domain | TSP1 | 6.42e-04 | 65 | 199 | 5 | SM00209 | |
| Domain | TSP1_rpt | 6.42e-04 | 65 | 199 | 5 | IPR000884 | |
| Domain | TSP1 | 6.42e-04 | 65 | 199 | 5 | PS50092 | |
| Domain | Myotonic_dystrophy_kinase_coil | 6.68e-04 | 4 | 199 | 2 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 6.68e-04 | 4 | 199 | 2 | PD011252 | |
| Domain | DMPK_coil | 6.68e-04 | 4 | 199 | 2 | PF08826 | |
| Domain | Death_domain | 6.95e-04 | 38 | 199 | 4 | IPR000488 | |
| Domain | DEATH_DOMAIN | 6.95e-04 | 38 | 199 | 4 | PS50017 | |
| Domain | PH | DOCK11 MYO10 SYNGAP1 GRK3 ANLN CDC42BPA ARHGAP10 CDC42BPB AKAP13 | 8.03e-04 | 229 | 199 | 9 | PF00169 |
| Domain | RA_dom | 8.46e-04 | 40 | 199 | 4 | IPR000159 | |
| Domain | DISINTEGRIN_1 | 8.46e-04 | 40 | 199 | 4 | PS00427 | |
| Domain | Reprolysin | 8.46e-04 | 40 | 199 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 8.46e-04 | 40 | 199 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 8.46e-04 | 40 | 199 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 8.46e-04 | 40 | 199 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 9.30e-04 | 41 | 199 | 4 | IPR001762 | |
| Domain | ARM-type_fold | USP34 WAPL DOCK11 PSME4 RIPOR1 PPP4R1 UBR4 ODAD2 API5 PPP2R1B INF2 | 1.06e-03 | 339 | 199 | 11 | IPR016024 |
| Domain | PROTEIN_KINASE_ATP | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 1.33e-03 | 459 | 199 | 13 | PS00107 |
| Domain | EGF_1 | 1.70e-03 | 255 | 199 | 9 | PS00022 | |
| Domain | - | 1.73e-03 | 207 | 199 | 8 | 1.25.40.10 | |
| Domain | ADAM_spacer1 | 1.80e-03 | 23 | 199 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.80e-03 | 23 | 199 | 3 | PF05986 | |
| Domain | P-loop_NTPase | MYH2 MYH4 MYH9 MYO10 SMC1A TOR4A SRCAP TRIP13 MYO3A MYO18B DDX24 RAB3B DHX40 DDX55 DNAH7 DNAH1 ARF6 MYH14 IRGC | 1.84e-03 | 848 | 199 | 19 | IPR027417 |
| Domain | EGF-like_CS | 1.99e-03 | 261 | 199 | 9 | IPR013032 | |
| Domain | Kinase-like_dom | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB MACF1 NEK11 NLK | 2.07e-03 | 542 | 199 | 14 | IPR011009 |
| Domain | EGF_2 | 2.21e-03 | 265 | 199 | 9 | PS01186 | |
| Domain | Prot_kinase_dom | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 2.32e-03 | 489 | 199 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MYLK SPEG RPS6KC1 MYO3A TAOK3 BMPR2 GRK3 WNK3 RPS6KA4 CDC42BPA CDC42BPB NEK11 NLK | 2.49e-03 | 493 | 199 | 13 | PS50011 |
| Domain | Rho_GTPase_activation_prot | 2.50e-03 | 88 | 199 | 5 | IPR008936 | |
| Domain | TPR_1 | 2.76e-03 | 90 | 199 | 5 | IPR001440 | |
| Domain | TPR_1 | 2.76e-03 | 90 | 199 | 5 | PF00515 | |
| Domain | DEATH | 2.89e-03 | 27 | 199 | 3 | SM00005 | |
| Domain | AGC-kinase_C | 2.98e-03 | 56 | 199 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.98e-03 | 56 | 199 | 4 | PS51285 | |
| Domain | S_TK_X | 2.98e-03 | 56 | 199 | 4 | SM00133 | |
| Domain | AC_N | 3.03e-03 | 8 | 199 | 2 | IPR032628 | |
| Domain | Adcy | 3.03e-03 | 8 | 199 | 2 | IPR030672 | |
| Domain | AC_N | 3.03e-03 | 8 | 199 | 2 | PF16214 | |
| Domain | PH | DOCK11 MYO10 SYNGAP1 GRK3 ANLN CDC42BPA ARHGAP10 CDC42BPB AKAP13 | 3.04e-03 | 278 | 199 | 9 | SM00233 |
| Domain | TPR_repeat | 3.04e-03 | 133 | 199 | 6 | IPR019734 | |
| Domain | PH_DOMAIN | DOCK11 MYO10 SYNGAP1 GRK3 ANLN CDC42BPA ARHGAP10 CDC42BPB AKAP13 | 3.11e-03 | 279 | 199 | 9 | PS50003 |
| Domain | PH_domain | DOCK11 MYO10 SYNGAP1 GRK3 ANLN CDC42BPA ARHGAP10 CDC42BPB AKAP13 | 3.18e-03 | 280 | 199 | 9 | IPR001849 |
| Domain | TPR-like_helical_dom | 3.59e-03 | 233 | 199 | 8 | IPR011990 | |
| Domain | EGF | 3.78e-03 | 235 | 199 | 8 | SM00181 | |
| Domain | EGF_3 | 3.78e-03 | 235 | 199 | 8 | PS50026 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.02e-06 | 33 | 147 | 6 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.02e-06 | 33 | 147 | 6 | M11575 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 5.15e-06 | 43 | 147 | 6 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 5.15e-06 | 43 | 147 | 6 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 5.15e-06 | 43 | 147 | 6 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 5.91e-06 | 44 | 147 | 6 | MM15709 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 6.35e-06 | 26 | 147 | 5 | M47456 | |
| Pathway | REACTOME_GPER1_SIGNALING | 6.76e-06 | 45 | 147 | 6 | M45008 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 7.73e-06 | 27 | 147 | 5 | M47454 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 8.85e-06 | 71 | 147 | 7 | MM14491 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 9.93e-06 | 48 | 147 | 6 | M10775 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.57e-05 | 31 | 147 | 5 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY | 1.57e-05 | 31 | 147 | 5 | M47455 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 1.59e-05 | 52 | 147 | 6 | M920 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.66e-05 | 60 | 147 | 6 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.66e-05 | 60 | 147 | 6 | M976 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 3.89e-05 | 19 | 147 | 4 | MM15021 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 3.89e-05 | 19 | 147 | 4 | M926 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 4.21e-05 | 90 | 147 | 7 | M6467 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 4.83e-05 | 20 | 147 | 4 | MM15572 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 4.83e-05 | 20 | 147 | 4 | M27853 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.98e-05 | 39 | 147 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.98e-05 | 39 | 147 | 5 | MM15165 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 5.92e-05 | 21 | 147 | 4 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 5.92e-05 | 21 | 147 | 4 | MM15159 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 7.17e-05 | 22 | 147 | 4 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 7.17e-05 | 22 | 147 | 4 | M841 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 8.61e-05 | 23 | 147 | 4 | MM15033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 8.61e-05 | 23 | 147 | 4 | M47549 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.01e-04 | 45 | 147 | 5 | MM15040 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 1.03e-04 | 24 | 147 | 4 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 1.03e-04 | 24 | 147 | 4 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 1.03e-04 | 24 | 147 | 4 | M18308 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 1.03e-04 | 24 | 147 | 4 | M47460 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 1.03e-04 | 24 | 147 | 4 | MM14794 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 1.21e-04 | 25 | 147 | 4 | MM15056 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 1.21e-04 | 25 | 147 | 4 | M811 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.21e-04 | 25 | 147 | 4 | M14301 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.35e-04 | 108 | 147 | 7 | M17034 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.42e-04 | 26 | 147 | 4 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 1.42e-04 | 26 | 147 | 4 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 1.42e-04 | 26 | 147 | 4 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 1.42e-04 | 26 | 147 | 4 | M47557 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH9 MYLK DOCK11 TAOK3 ANLN ARHGAP44 PLXNB1 CDC42BPA ARHGAP10 ANKRD26 SHMT2 KLC4 CDC42BPB SYDE1 PPP2R1B MYH14 AKAP13 TOR1AIP1 | 1.43e-04 | 649 | 147 | 18 | MM15690 |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.50e-04 | 77 | 147 | 6 | MM15044 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 1.56e-04 | 188 | 147 | 9 | M4844 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.65e-04 | 27 | 147 | 4 | MM15664 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.85e-04 | 80 | 147 | 6 | M800 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 1.91e-04 | 28 | 147 | 4 | M10679 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 2.20e-04 | 29 | 147 | 4 | M47466 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.52e-04 | 30 | 147 | 4 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 2.52e-04 | 30 | 147 | 4 | MM14542 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 2.87e-04 | 31 | 147 | 4 | MM15094 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY | 2.87e-04 | 31 | 147 | 4 | M47459 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 2.87e-04 | 31 | 147 | 4 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 2.87e-04 | 31 | 147 | 4 | M47541 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 3.25e-04 | 32 | 147 | 4 | M861 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 3.25e-04 | 32 | 147 | 4 | M14309 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 3.25e-04 | 32 | 147 | 4 | MM15148 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.25e-04 | 32 | 147 | 4 | MM15143 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 3.25e-04 | 32 | 147 | 4 | M47962 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 3.25e-04 | 32 | 147 | 4 | MM14983 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 3.34e-04 | 165 | 147 | 8 | M39400 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 3.67e-04 | 33 | 147 | 4 | MM15027 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 3.67e-04 | 33 | 147 | 4 | MM15020 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 3.67e-04 | 33 | 147 | 4 | M47550 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 3.67e-04 | 33 | 147 | 4 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 3.67e-04 | 33 | 147 | 4 | M10322 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 3.67e-04 | 33 | 147 | 4 | M9379 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 3.74e-04 | 91 | 147 | 6 | M39426 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 4.13e-04 | 34 | 147 | 4 | M42555 | |
| Pathway | REACTOME_CA2_PATHWAY | 4.62e-04 | 62 | 147 | 5 | M27321 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 4.62e-04 | 35 | 147 | 4 | M1075 | |
| Pathway | KEGG_TIGHT_JUNCTION | 4.62e-04 | 132 | 147 | 7 | M11355 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 4.83e-04 | 219 | 147 | 9 | M29836 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH9 MYLK DOCK11 TAOK3 ANLN ARHGAP44 PLXNB1 CDC42BPA ARHGAP10 ANKRD26 SHMT2 KLC4 CDC42BPB SYDE1 PPP2R1B MYH14 AKAP13 TOR1AIP1 | 5.03e-04 | 720 | 147 | 18 | M41838 |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 5.06e-04 | 134 | 147 | 7 | M29840 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 5.16e-04 | 36 | 147 | 4 | MM14544 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.74e-04 | 37 | 147 | 4 | M27134 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 6.17e-04 | 66 | 147 | 5 | M39684 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 6.36e-04 | 38 | 147 | 4 | M27656 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK11 TAOK3 ANLN ARHGAP44 PLXNB1 CDC42BPA ARHGAP10 ANKRD26 SHMT2 CDC42BPB SYDE1 AKAP13 TOR1AIP1 | 6.85e-04 | 439 | 147 | 13 | MM15595 |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 7.03e-04 | 39 | 147 | 4 | MM15003 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 7.08e-04 | 68 | 147 | 5 | M27303 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 7.75e-04 | 40 | 147 | 4 | MM15115 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK11 TAOK3 ANLN ARHGAP44 PLXNB1 CDC42BPA ARHGAP10 ANKRD26 SHMT2 CDC42BPB SYDE1 AKAP13 TOR1AIP1 | 8.61e-04 | 450 | 147 | 13 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_WNT | 9.02e-04 | 239 | 147 | 9 | MM14756 | |
| Pathway | REACTOME_HEMOSTASIS | DOCK11 DGKQ TOR4A GLG1 GNB1 GNB2 GNB3 ADAMTS13 BCAR1 KLC4 TF TGFB2 PPP2R1B GNB4 ATP1B2 | 9.17e-04 | 571 | 147 | 15 | MM14472 |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 9.34e-04 | 42 | 147 | 4 | M791 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.74e-04 | 109 | 147 | 6 | MM15164 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.03e-03 | 151 | 147 | 7 | M39329 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.11e-03 | 20 | 147 | 3 | M18415 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.11e-03 | 44 | 147 | 4 | M26969 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.17e-03 | 76 | 147 | 5 | MM15051 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.29e-03 | 21 | 147 | 3 | M27494 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.29e-03 | 157 | 147 | 7 | M4904 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.32e-03 | 46 | 147 | 4 | M39828 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 1.50e-03 | 257 | 147 | 9 | MM15454 | |
| Pathway | WP_CELL_CYCLE | 1.60e-03 | 120 | 147 | 6 | M39650 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.66e-03 | 211 | 147 | 8 | MM14502 | |
| Pubmed | USP34 WAPL STUB1 CNST SMC1A NARS1 SYNGAP1 EFEMP1 FAM120A ADAMTS9 SGSM2 JAKMIP1 GNB1 BRWD1 PPP4R1 SYNM RBL2 SYNE1 UBR4 APBA1 TF CDC42BPB JPH1 P4HTM MYH14 SENP6 MACF1 ANKRD24 LTBP3 RAPGEF2 | 1.78e-10 | 1285 | 207 | 30 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 ANKS6 MYO10 SPEG DGKQ TOR4A SRCAP GADD45A PSME4 SGSM2 ARHGAP44 RIPOR1 SIPA1L2 BAHCC1 CDC42BPA ANXA11 UBR4 CDC42BPB CCND3 KANSL1 INF2 IL17RE AKAP13 CEP131 LTBP3 ESPL1 PRRT4 | 5.95e-10 | 1105 | 207 | 27 | 35748872 |
| Pubmed | 1.22e-09 | 4 | 207 | 4 | 1543505 | ||
| Pubmed | The role of G protein beta subunits in the release of ATP from human erythrocytes. | 1.22e-09 | 4 | 207 | 4 | 12512701 | |
| Pubmed | USP34 WAPL STUB1 EMILIN3 CRACR2B KEAP1 SRCAP TRIP13 NSRP1 FAM120A SIPA1L2 TAF9 DDX24 BAHCC1 BRWD1 SFSWAP ARHGAP10 PPFIA3 TF JPH1 TAF9B NEURL1 MACF1 LZTS2 RAPGEF2 ANKS3 | 3.42e-09 | 1116 | 207 | 26 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRIP13 ADCY1 NSRP1 BMPR2 FAM120A GRK3 SGSM2 ARHGAP44 ACSF3 RIPOR1 NTN1 BOD1L1 HOOK2 BAIAP3 CDC42BPA ARHGAP10 BCAR1 CDC42BPB DNAH1 CCND3 PPP2R1B INF2 MYH14 CDYL2 MACF1 AKAP13 ANKRD24 LZTS2 RAPGEF2 NLK | 5.49e-09 | 1489 | 207 | 30 | 28611215 |
| Pubmed | USP34 WAPL CNST SRCAP RPS6KC1 MED24 TAOK3 POLR3D PSME4 ANLN GLG1 BOD1L1 TIMELESS BAIAP3 PLXNB1 BRWD1 SHMT2 IRGQ ANKRD50 CCDC77 ZSCAN10 INF2 MACF1 ESPL1 CCDC171 | 8.57e-09 | 1084 | 207 | 25 | 11544199 | |
| Pubmed | 1.81e-08 | 6 | 207 | 4 | 16884933 | ||
| Pubmed | 2.69e-08 | 31 | 207 | 6 | 12626323 | ||
| Pubmed | SMC1A SRP68 FAM120A ADAMTS9 HOOK2 MYO18B USP1 CDC42BPA SYNE1 ANKRD26 ANKRD50 CDC42BPB JPH1 MYH14 MACF1 SNAPC3 | 5.86e-08 | 497 | 207 | 16 | 23414517 | |
| Pubmed | 8.38e-08 | 8 | 207 | 4 | 2328987 | ||
| Pubmed | 1.50e-07 | 9 | 207 | 4 | 10339615 | ||
| Pubmed | Genomic organization of the murine G protein beta subunit genes and related processed pseudogenes. | 2.08e-07 | 3 | 207 | 3 | 11913780 | |
| Pubmed | USP34 MYH9 ANKS6 BET1 SRP68 GTF3C3 CDC42BPA SFSWAP SYNM ANKRD26 ANKRD50 CDC42BPB DNAH7 SYDE1 CRB1 ARF6 CEP131 RAPGEF2 TOR1AIP1 | 2.42e-07 | 777 | 207 | 19 | 35844135 | |
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 2.49e-07 | 10 | 207 | 4 | 28334111 | |
| Pubmed | 2.49e-07 | 10 | 207 | 4 | 9733924 | ||
| Pubmed | STUB1 NSRP1 GTF3C3 PM20D2 FAM120A GLG1 SIPA1L2 DDX24 CDC42BPA SYNM SYNE1 UBR4 BAG5 ANKRD26 SHMT2 VARS2 TRAPPC8 CCDC77 CDC42BPB JPH1 INF2 MACF1 AKAP13 CEP131 LZTS2 ESPL1 TOR1AIP1 | 2.76e-07 | 1487 | 207 | 27 | 33957083 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TRADD ANKS6 MYO10 SRP68 KEAP1 GTF3C3 POLR3D RIPOR1 HOOK2 GNB1 GNB2 PPP4R1 TNIP2 ANKRD50 SYDE1 RNF146 GNB4 SNAPC3 LZTS2 RAPGEF2 ESPL1 ANKS3 | 3.02e-07 | 1038 | 207 | 22 | 26673895 |
| Pubmed | 3.89e-07 | 11 | 207 | 4 | 10644457 | ||
| Pubmed | A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. | 3.89e-07 | 11 | 207 | 4 | 25982117 | |
| Pubmed | Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. | 5.81e-07 | 12 | 207 | 4 | 20186915 | |
| Pubmed | Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers. | 5.81e-07 | 12 | 207 | 4 | 16301321 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 5.81e-07 | 12 | 207 | 4 | 25770910 | |
| Pubmed | 5.81e-07 | 12 | 207 | 4 | 8636150 | ||
| Pubmed | 6.26e-07 | 28 | 207 | 5 | 8858601 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 8.28e-07 | 4 | 207 | 3 | 11029314 | |
| Pubmed | The cationic region of Rhes mediates its interactions with specific Gbeta subunits. | 8.28e-07 | 4 | 207 | 3 | 19255495 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | PTGFRN GLG1 GNB2 COL6A2 CDC42BPA ANXA11 SHMT2 TGM2 INF2 AKAP13 | 1.15e-06 | 226 | 207 | 10 | 37839992 |
| Pubmed | 1.58e-06 | 15 | 207 | 4 | 12486123 | ||
| Pubmed | SMC1A PTGFRN FAM120A ADAMTS9 SH3TC2 THSD7A SYNM ANKRD26 VARS2 TRAPPC8 MON1B CDC42BPB MACF1 ANKRD24 | 1.77e-06 | 493 | 207 | 14 | 15368895 | |
| Pubmed | MYH2 MYH4 MYH9 MYLK SRCAP TRIP13 RPS6KC1 BOD1L1 JAKMIP1 GNB1 SIPA1L2 USP1 RAB3B BAHCC1 PCDHGA10 KRT33A SYNE1 PCDHGA2 UBR4 ANKRD26 CCDC77 DDX55 KIAA0825 MYH14 MACF1 | 1.82e-06 | 1442 | 207 | 25 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 WAPL SMC1A NARS1 SRP68 TOR4A SRCAP TRIP13 GTF3C3 FAM120A ADSL PSME4 ANLN GNB2 DDX24 DHX40 UBR4 SHMT2 TGM2 KANSL1 INF2 MYH14 MACF1 AKAP13 | 2.01e-06 | 1353 | 207 | 24 | 29467282 |
| Pubmed | WAPL TAOK3 EFEMP1 FAM120A PSME4 TIMELESS HOOK2 PLXNB1 PPP4R1 COL6A2 DHX40 ANKRD50 DDX55 SYDE1 TGM2 AKAP13 | 2.05e-06 | 650 | 207 | 16 | 38777146 | |
| Pubmed | MYH2 MYH4 SMC1A EMILIN3 KEAP1 TRIP13 GTF3C3 ADSL GLG1 SHMT2 IRGQ TRAPPC8 MON1B | 2.52e-06 | 437 | 207 | 13 | 20562859 | |
| Pubmed | 2.73e-06 | 17 | 207 | 4 | 19376773 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 STUB1 SRCAP TTC4 SIPA1L2 TAF9 PPP4R1 DHX40 ANKRD26 BCAR1 SENP6 UNK MACF1 CEP131 LZTS2 | 2.81e-06 | 588 | 207 | 15 | 38580884 |
| Pubmed | 4.07e-06 | 153 | 207 | 8 | 10718198 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 16371464 | ||
| Pubmed | 4.10e-06 | 6 | 207 | 3 | 30044719 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK11 BMPR2 ANLN BOD1L1 SIPA1L2 WNK3 CDC42BPA ANKRD26 BCAR1 KLC4 DNAH7 SYDE1 PPM1A NEURL1 MACF1 AKAP13 CEP131 RAPGEF2 | 4.59e-06 | 861 | 207 | 18 | 36931259 |
| Pubmed | MYH9 DOCK11 KEAP1 SYNGAP1 FAM120A ARHGAP44 JAKMIP1 GNB1 GNB2 RAB3B WNK3 SYT3 SYNE1 UBR4 PPFIA3 CDC42BPB MACF1 CEP131 RAPGEF2 | 5.66e-06 | 963 | 207 | 19 | 28671696 | |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 5.92e-06 | 161 | 207 | 8 | 32572027 | |
| Pubmed | Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB. | 6.40e-06 | 44 | 207 | 5 | 30024968 | |
| Pubmed | 7.15e-06 | 7 | 207 | 3 | 10570481 | ||
| Pubmed | 1.14e-05 | 8 | 207 | 3 | 9789084 | ||
| Pubmed | 1.14e-05 | 8 | 207 | 3 | 24462769 | ||
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 1.14e-05 | 8 | 207 | 3 | 17429076 | |
| Pubmed | MYH9 STUB1 NSRP1 FAM120A ANLN TIMELESS DDX24 BCAR1 KLC4 PPP1R14B AKAP13 CEP131 ANKS3 | 1.14e-05 | 503 | 207 | 13 | 16964243 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | KEAP1 TAOK3 BMPR2 ANLN GNB2 CDC42BPA ANKRD50 CDC42BPB JPH1 LZTS2 TOR1AIP1 | 1.81e-05 | 377 | 207 | 11 | 38117590 |
| Pubmed | USP34 WAPL KEAP1 PSME4 PLXNB1 CDC42BPA ANKRD50 DDX55 SENP6 UNK LZTS2 ESPL1 ANKS3 | 1.94e-05 | 529 | 207 | 13 | 14621295 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 MYH9 STUB1 SMC1A NARS1 SRP68 TTC4 TRIP13 ADSL PSME4 RIPOR1 TIMELESS PPP4R1 UBR4 BAG5 SHMT2 API5 BCAR1 KLC4 TGM2 PPP2R1B MYH14 MACF1 | 2.12e-05 | 1455 | 207 | 23 | 22863883 |
| Pubmed | 2.42e-05 | 10 | 207 | 3 | 11167130 | ||
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 2.42e-05 | 10 | 207 | 3 | 24825879 | |
| Pubmed | SRP68 SRCAP TRIP13 GTF3C3 MED24 POLR3D ANLN TAF9 KLC4 ARF6 TAF9B | 2.47e-05 | 390 | 207 | 11 | 17643375 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH9 SMC1A SRP68 SRCAP NSRP1 GTF3C3 SYNGAP1 GNB1 SIPA1L2 TAF9 DDX24 PLXNB1 CDC42BPA SFSWAP SYNE1 SHMT2 CBFA2T3 DDX55 MACF1 | 2.84e-05 | 1082 | 207 | 19 | 38697112 |
| Pubmed | 3.27e-05 | 101 | 207 | 6 | 9872452 | ||
| Pubmed | 3.31e-05 | 11 | 207 | 3 | 34932372 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYH9 STUB1 SYNGAP1 EFEMP1 ARHGAP44 HOOK2 JAKMIP1 TNIP2 KLC4 ANKRD24 LTBP3 LZTS2 ANKS3 | 3.49e-05 | 560 | 207 | 13 | 21653829 |
| Pubmed | Nuclear exclusion of separase prevents cohesin cleavage in interphase cells. | 3.53e-05 | 2 | 207 | 2 | 17102637 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 20525682 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 8621670 | ||
| Pubmed | Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine. | 3.53e-05 | 2 | 207 | 2 | 20635912 | |
| Pubmed | Interaction between the pRb2/p130 C-terminal domain and the N-terminal portion of cyclin D3. | 3.53e-05 | 2 | 207 | 2 | 10572252 | |
| Pubmed | Cloning and chromosomal localization of human Cdc42-binding protein kinase beta. | 3.53e-05 | 2 | 207 | 2 | 10198171 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 11934887 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 19854717 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 33971927 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 29545013 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 25230327 | ||
| Pubmed | In vivo functional analysis of the histone 3-like TAF9 and a TAF9-related factor, TAF9L. | 3.53e-05 | 2 | 207 | 2 | 12837753 | |
| Pubmed | Interaction of the two cytosolic domains of mammalian adenylyl cyclase. | 3.53e-05 | 2 | 207 | 2 | 8692867 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 18263588 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 22420028 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 26327442 | ||
| Pubmed | Myosin-IIA and ICAM-1 regulate the interchange between two distinct modes of T cell migration. | 3.53e-05 | 2 | 207 | 2 | 19201857 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 26568304 | ||
| Pubmed | Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3. | 3.53e-05 | 2 | 207 | 2 | 24998259 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 34056735 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 36753416 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 31653576 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 31389735 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 11226577 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 12514189 | ||
| Pubmed | Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer. | 3.53e-05 | 2 | 207 | 2 | 16301118 | |
| Pubmed | Human MRCKalpha is regulated by cellular iron levels and interferes with transferrin iron uptake. | 3.53e-05 | 2 | 207 | 2 | 20188707 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 1979057 | ||
| Pubmed | Netrin-1-mediated axon guidance in mouse embryonic stem cells overexpressing neurogenin-1. | 3.53e-05 | 2 | 207 | 2 | 22512716 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 21102503 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 34374341 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 MYH4 MYH9 MYO10 SMC1A SRP68 KEAP1 TRIP13 ADSL GNB2 TAF9 DDX24 USP1 USP49 DHX40 BAG5 SHMT2 PPP2R1B | 3.60e-05 | 1005 | 207 | 18 | 19615732 |
| Pubmed | SRP68 KEAP1 SRCAP MED24 ADSL ANLN DHX40 ANKRD26 CCDC77 DDX55 MYH14 GNB4 CEP131 TOR1AIP1 | 3.62e-05 | 645 | 207 | 14 | 25281560 | |
| Pubmed | MYO10 SPEG ADCY2 SGSM2 RIPOR1 BOD1L1 SIPA1L2 BAIAP3 SYNE1 KANSL1 MACF1 | 3.64e-05 | 407 | 207 | 11 | 12693553 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 MYH9 PTGFRN GTF3C3 MELTF BMPR2 EFEMP1 ADSL GLG1 JMJD8 TIMELESS PLXNB1 DDX55 TGFB2 TGM2 P4HTM LTBP3 TNFRSF1A NAGPA TOR1AIP1 | 3.67e-05 | 1201 | 207 | 20 | 35696571 |
| Pubmed | USP34 WAPL SRP68 TTC4 FAM120A ANLN BOD1L1 USP1 JPH1 TGM2 UNK AKAP13 CEP131 ESPL1 TOR1AIP1 | 3.74e-05 | 733 | 207 | 15 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH4 MYH9 DOCK11 NARS1 SRP68 RPS6KC1 EDAR ADAMTS9 BOD1L1 JAKMIP1 UBR4 PPFIA3 PPM1A AKAP13 CXCR2 | 3.91e-05 | 736 | 207 | 15 | 29676528 |
| Pubmed | NAB1 SYNGAP1 JMJD8 ADAMTS20 RIPOR1 SIPA1L2 CNTN2 IP6K2 COL6A2 SHMT2 IRGQ BCAR1 JPH1 ADAMTS10 ZSCAN10 RNF146 ANKRD24 LZTS2 RAPGEF2 TOR1AIP1 | 4.31e-05 | 1215 | 207 | 20 | 15146197 | |
| Pubmed | 4.39e-05 | 12 | 207 | 3 | 34342229 | ||
| Pubmed | 4.40e-05 | 156 | 207 | 7 | 22008794 | ||
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 4.91e-05 | 34 | 207 | 4 | 25925205 | |
| Pubmed | 4.96e-05 | 159 | 207 | 7 | 30581152 | ||
| Interaction | GNG10 interactions | 4.10e-06 | 43 | 201 | 6 | int:GNG10 | |
| Interaction | GNGT2 interactions | 4.47e-06 | 12 | 201 | 4 | int:GNGT2 | |
| Interaction | GNGT1 interactions | 5.21e-06 | 26 | 201 | 5 | int:GNGT1 | |
| Interaction | KRT8 interactions | MYH9 TRIP13 ANLN SIPA1L2 DDX24 SYNM KRT33A TNIP2 UBR4 ANKRD26 CCDC77 KLC4 TGM2 UNK CEP131 LZTS2 | 9.59e-06 | 441 | 201 | 16 | int:KRT8 |
| Interaction | KCTD2 interactions | 1.76e-05 | 55 | 201 | 6 | int:KCTD2 | |
| Interaction | ADAMTS12 interactions | 1.76e-05 | 55 | 201 | 6 | int:ADAMTS12 | |
| Interaction | GNG11 interactions | 2.06e-05 | 17 | 201 | 4 | int:GNG11 | |
| Interaction | RGS6 interactions | 2.63e-05 | 18 | 201 | 4 | int:RGS6 | |
| Interaction | SASS6 interactions | KEAP1 SIPA1L2 TNIP2 UBR4 ANKRD26 CCDC77 CEP131 LZTS2 CCDC102B | 3.20e-05 | 159 | 201 | 9 | int:SASS6 |
| Interaction | GNG7 interactions | 4.11e-05 | 20 | 201 | 4 | int:GNG7 | |
| Interaction | GNG13 interactions | 5.26e-05 | 41 | 201 | 5 | int:GNG13 | |
| Interaction | TOP3B interactions | USP34 ANKS6 MYO10 SPEG SMC1A DGKQ TOR4A SRCAP GADD45A FAM120A PSME4 SGSM2 ARHGAP44 RIPOR1 SIPA1L2 BAHCC1 CDC42BPA ANXA11 UBR4 APBA1 CDC42BPB CCND3 KANSL1 INF2 IL17RE UNK AKAP13 CEP131 LTBP3 ESPL1 PRRT4 | 5.89e-05 | 1470 | 201 | 31 | int:TOP3B |
| Interaction | GNAS interactions | MYH9 STUB1 BET1 ADCY2 SYNGAP1 ANLN GNB1 GNB2 TNIP2 SHMT2 GNB4 | 7.26e-05 | 264 | 201 | 11 | int:GNAS |
| GeneFamily | Myosin heavy chains | 3.70e-06 | 15 | 134 | 4 | 1098 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.03e-05 | 19 | 134 | 4 | 50 | |
| GeneFamily | Transferrins | 1.63e-04 | 3 | 134 | 2 | 908 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.26e-03 | 29 | 134 | 3 | 396 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.66e-03 | 115 | 134 | 5 | 769 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.36e-03 | 10 | 134 | 2 | 53 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | MYO10 SRP68 FAM120A BRWD1 SFSWAP ARHGAP10 KRT33A UBR4 CBFA2T3 KLC4 | 4.25e-06 | 199 | 206 | 10 | M3846 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | MYH9 SMC1A ANLN CDC42BPA ARHGAP10 BCAR1 ARF6 AKAP13 CEP131 ESPL1 | 4.25e-06 | 199 | 206 | 10 | M5893 |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP | 5.20e-06 | 160 | 206 | 9 | M6863 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 2.83e-05 | 152 | 206 | 8 | M39243 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 3.10e-05 | 200 | 206 | 9 | M9341 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | SMC1A ADCY2 PAX8 ADAMTS20 TIMELESS COL6A2 EVC2 COMP PPP1R14B DNAH1 TGM2 NEURL1 ESPL1 | 4.62e-05 | 437 | 206 | 13 | M1610 |
| Coexpression | NGUYEN_NOTCH1_TARGETS_DN | 5.00e-05 | 83 | 206 | 6 | M14650 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 5.30e-05 | 166 | 206 | 8 | M7722 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP | 6.01e-05 | 169 | 206 | 8 | M6700 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#2_top-relative-expression-ranked_200 | 1.62e-05 | 85 | 201 | 7 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_200_k2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK DOCK11 TAOK3 COL6A2 SYNM ANKRD50 TGFB2 CTNNA3 CCDC102B ATP1B2 | 3.59e-08 | 200 | 207 | 10 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-07 | 172 | 207 | 9 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-07 | 177 | 207 | 9 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-07 | 184 | 207 | 9 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-07 | 187 | 207 | 9 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-07 | 187 | 207 | 9 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MYLK MYO10 COL6A2 SYNM ARHGAP10 PCDHA10 CBFA2T3 SYDE1 CCDC102B | 2.90e-07 | 191 | 207 | 9 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MYLK MYO10 COL6A2 SYNM ARHGAP10 PCDHA10 CBFA2T3 SYDE1 CCDC102B | 2.90e-07 | 191 | 207 | 9 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.28e-07 | 200 | 207 | 9 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-06 | 180 | 207 | 8 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-06 | 185 | 207 | 8 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-06 | 187 | 207 | 8 | 629b3e05840eb10e598b8dfaabd92ebe02f9995a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 ADAMTS9 COL6A2 SYNM ARHGAP10 CBFA2T3 ADAMTS10 CCDC102B | 2.76e-06 | 187 | 207 | 8 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-06 | 187 | 207 | 8 | 269145d71576cbe8fa217090c8aac82d915dbc04 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-06 | 187 | 207 | 8 | 7a50aded3243bef2075fb3ec550939ce0694919a | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 189 | 207 | 8 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 189 | 207 | 8 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 189 | 207 | 8 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-06 | 193 | 207 | 8 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-06 | 194 | 207 | 8 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 4.06e-06 | 197 | 207 | 8 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 207 | 8 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.38e-06 | 199 | 207 | 8 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.38e-06 | 199 | 207 | 8 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.38e-06 | 199 | 207 | 8 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.24e-06 | 155 | 207 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.24e-06 | 155 | 207 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-06 | 157 | 207 | 7 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 165 | 207 | 7 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 165 | 207 | 7 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.56e-05 | 171 | 207 | 7 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-05 | 181 | 207 | 7 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-05 | 182 | 207 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-05 | 183 | 207 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 183 | 207 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 184 | 207 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-05 | 185 | 207 | 7 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 185 | 207 | 7 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.59e-05 | 185 | 207 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-05 | 186 | 207 | 7 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-05 | 186 | 207 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 186 | 207 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 187 | 207 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-05 | 187 | 207 | 7 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.77e-05 | 187 | 207 | 7 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 188 | 207 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 189 | 207 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 189 | 207 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.97e-05 | 189 | 207 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 190 | 207 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-05 | 190 | 207 | 7 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-05 | 191 | 207 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 192 | 207 | 7 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-05 | 192 | 207 | 7 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 192 | 207 | 7 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 192 | 207 | 7 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 192 | 207 | 7 | ee9a23a4f00424a50bd7907cf3b12dc50027877e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 193 | 207 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 193 | 207 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 207 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.51e-05 | 194 | 207 | 7 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-05 | 194 | 207 | 7 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 195 | 207 | 7 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-05 | 195 | 207 | 7 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 195 | 207 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 196 | 207 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 197 | 207 | 7 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 197 | 207 | 7 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-05 | 197 | 207 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.87e-05 | 197 | 207 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 197 | 207 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-05 | 198 | 207 | 7 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-05 | 198 | 207 | 7 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-05 | 198 | 207 | 7 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-05 | 198 | 207 | 7 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.99e-05 | 198 | 207 | 7 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-05 | 198 | 207 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-05 | 198 | 207 | 7 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 199 | 207 | 7 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Skin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.12e-05 | 199 | 207 | 7 | bcb78838a91cc7828680fb413fbacdb091c5fac0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.12e-05 | 199 | 207 | 7 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.12e-05 | 199 | 207 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.12e-05 | 199 | 207 | 7 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 199 | 207 | 7 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.12e-05 | 199 | 207 | 7 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.12e-05 | 199 | 207 | 7 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 207 | 7 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 207 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.26e-05 | 200 | 207 | 7 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 207 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 4.26e-05 | 200 | 207 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 207 | 7 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 207 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| Drug | purealin | 4.55e-08 | 58 | 203 | 8 | CID006419303 | |
| Drug | formycin triphosphate | 3.35e-07 | 51 | 203 | 7 | CID000122274 | |
| Drug | blebbistatin | 9.98e-07 | 116 | 203 | 9 | CID003476986 | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | SMC1A TOR4A SRCAP POLR3D SPOCK3 GLG1 BAHCC1 ANKRD26 PPFIA3 TGFB2 NEK11 | 1.75e-06 | 198 | 203 | 11 | 6426_DN |
| Drug | testosterone enanthate | USP34 PSME4 GLG1 GNB1 DDX24 USP1 COL6A2 RBL2 BAG5 API5 PPM1A RSAD2 NEURL1 MACF1 AKAP13 LTBP3 RAPGEF2 NLK | 4.37e-06 | 575 | 203 | 18 | ctd:C004648 |
| Drug | clenbuterol | 5.36e-06 | 142 | 203 | 9 | CID000002783 | |
| Drug | Methacholine Chloride | 1.03e-05 | 16 | 203 | 4 | ctd:D016210 | |
| Drug | HBED | 1.03e-05 | 16 | 203 | 4 | CID000037336 | |
| Drug | B0683 | 1.03e-05 | 117 | 203 | 8 | CID006398969 | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | TRADD SMC1A TOR4A SRCAP STC1 BMPR2 PSME4 SGSM2 CDC42BPA SYNE1 | 1.15e-05 | 197 | 203 | 10 | 7069_DN |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | MYLK ARHGAP44 ADAMTS20 BAIAP3 BAHCC1 PCDHGA10 PPFIA3 TASL CDC42BPB MYH14 | 1.15e-05 | 197 | 203 | 10 | 4084_DN |
| Drug | NSC611747 | MYH2 MYH4 MYLK MYO10 RPS6KC1 MYO3A GRK3 MYO18B WNK3 RPS6KA4 PPM1A PPP2R1B AKAP13 | 1.78e-05 | 352 | 203 | 13 | CID000002534 |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.74e-05 | 174 | 203 | 9 | 864_UP | |
| Drug | eye gene | MYH2 MYH4 MYH9 MYLK MYO10 ADCY1 ADCY2 MYO3A MYO18B GNB3 EVC2 TNIP2 MYH14 | 2.92e-05 | 369 | 203 | 13 | CID000004782 |
| Drug | S-(-)-Etomoxir | 3.21e-05 | 100 | 203 | 7 | CID000060765 | |
| Drug | trifluoperazine | MYH2 MYH4 MYH9 MYLK MYO10 ADCY1 ADCY2 MYO3A GRK3 MYO18B ANXA11 MYH14 | 3.66e-05 | 324 | 203 | 12 | CID000005566 |
| Drug | blebbistatin | 3.78e-05 | 8 | 203 | 3 | ctd:C472645 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.02e-05 | 188 | 203 | 9 | 6735_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 5.68e-05 | 191 | 203 | 9 | 4283_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 6.16e-05 | 193 | 203 | 9 | 1647_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; HL60; HG-U133A | 6.41e-05 | 194 | 203 | 9 | 1404_UP | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 6653_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 2108_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 3783_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 6988_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A | 6.93e-05 | 196 | 203 | 9 | 1912_UP | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; PC3; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 7150_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 7310_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; PC3; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 6627_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 7373_UP | |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 5740_DN | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | STC1 GRK3 PAX8 BAHCC1 RPS6KA4 ADAMTS13 PPFIA3 CDC42BPB TGFB2 | 7.79e-05 | 199 | 203 | 9 | 454_UP |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | USP34 ADCY1 EDAR SGSM2 TIMELESS BAIAP3 PPP2R1B AKAP13 RAPGEF2 | 8.10e-05 | 200 | 203 | 9 | 4824_DN |
| Drug | pyrophosphate | MYH2 MYH4 MYH9 MYO10 NARS1 SRP68 ADCY1 ADCY2 MYO3A POLR3D MYO18B TAF9 IP6K2 SHMT2 VARS2 TF MYH14 | 8.44e-05 | 654 | 203 | 17 | CID000001023 |
| Drug | NSC339663 | 8.74e-05 | 250 | 203 | 10 | CID000003892 | |
| Drug | AC1L1IZ2 | MYH2 MYH4 MYH9 MYLK MYO10 ADCY1 MYO3A GRK3 MYO18B RBL2 MYH14 | 9.53e-05 | 304 | 203 | 11 | CID000004795 |
| Drug | carvedilol | 1.02e-04 | 161 | 203 | 8 | CID000002585 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 5.37e-05 | 31 | 198 | 4 | C1335167 | |
| Disease | Charcot-Marie-Tooth disease | 1.80e-04 | 42 | 198 | 4 | cv:C0007959 | |
| Disease | intestinal disease (implicated_via_orthology) | 2.66e-04 | 4 | 198 | 2 | DOID:5295 (implicated_via_orthology) | |
| Disease | polymyositis | 3.12e-04 | 20 | 198 | 3 | EFO_0003063 | |
| Disease | Malignant neoplasm of breast | MYH9 KEAP1 BMPR2 EFEMP1 BOD1L1 TIMELESS HSD17B8 PLXNB1 SYT3 SYNE1 UBR4 BCAR1 TRAPPC8 TGM2 MACF1 TEKT4 LZTS2 TOR1AIP1 | 3.56e-04 | 1074 | 198 | 18 | C0006142 |
| Disease | Infiltrating duct carcinoma of female breast | 3.62e-04 | 21 | 198 | 3 | C3165106 | |
| Disease | Neurodevelopmental Disorders | 4.17e-04 | 93 | 198 | 5 | C1535926 | |
| Disease | feeling emotionally hurt measurement | 5.50e-04 | 56 | 198 | 4 | EFO_0009599 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 6.60e-04 | 6 | 198 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | vital capacity | USP34 MYH2 MELTF EFEMP1 EDAR CROCC2 RIPOR1 MYO18B GNB1 SH3TC2 SYNE1 PCDHA10 ODAD2 TGFB2 ADAMTS10 KANSL1 CTNNA3 LTBP3 CCDC171 | 6.99e-04 | 1236 | 198 | 19 | EFO_0004312 |
| Disease | Abnormality of chromosome segregation | 7.15e-04 | 60 | 198 | 4 | HP_0002916 | |
| Disease | Hyalinosis, Segmental Glomerular | 8.61e-04 | 28 | 198 | 3 | C0086432 | |
| Disease | Nephronophthisis, familial juvenile | 9.20e-04 | 7 | 198 | 2 | C1855681 | |
| Disease | Epileptic encephalopathy | 1.06e-03 | 30 | 198 | 3 | C0543888 | |
| Disease | Vasogenic Brain Edema | 1.22e-03 | 8 | 198 | 2 | C0750969 | |
| Disease | Cytotoxic Brain Edema | 1.22e-03 | 8 | 198 | 2 | C0750970 | |
| Disease | Cytotoxic Cerebral Edema | 1.22e-03 | 8 | 198 | 2 | C0472388 | |
| Disease | Vasogenic Cerebral Edema | 1.22e-03 | 8 | 198 | 2 | C0472387 | |
| Disease | Brain Edema | 1.22e-03 | 8 | 198 | 2 | C1527311 | |
| Disease | Cerebral Edema | 1.22e-03 | 8 | 198 | 2 | C0006114 | |
| Disease | Large cell carcinoma of lung | 1.28e-03 | 32 | 198 | 3 | C0345958 | |
| Disease | joint hypermobility measurement | 1.40e-03 | 33 | 198 | 3 | EFO_0007905 | |
| Disease | carboxypeptidase B measurement | 1.56e-03 | 9 | 198 | 2 | EFO_0801453 | |
| Disease | Glaucoma | 1.56e-03 | 9 | 198 | 2 | C0017601 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.65e-03 | 75 | 198 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Kartagener Syndrome | 1.66e-03 | 35 | 198 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.66e-03 | 35 | 198 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.66e-03 | 35 | 198 | 3 | C4317124 | |
| Disease | Nonsyndromic genetic hearing loss | 1.73e-03 | 76 | 198 | 4 | cv:C5680182 | |
| Disease | Focal glomerulosclerosis | 1.81e-03 | 36 | 198 | 3 | C0017668 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.95e-03 | 10 | 198 | 2 | cv:CN327126 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | 3-methyl-2-oxobutyrate measurement | 1.95e-03 | 10 | 198 | 2 | EFO_0021020 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Focal segmental glomerulosclerosis | 1.95e-03 | 10 | 198 | 2 | cv:C0017668 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.95e-03 | 37 | 198 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | multiple sclerosis | NAB1 KEAP1 PTGFRN SGSM2 ACSF3 TNIP2 CBFA2T3 KANSL1 UNK AKAP13 TNFRSF1A | 2.37e-03 | 594 | 198 | 11 | MONDO_0005301 |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.37e-03 | 11 | 198 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 2.37e-03 | 11 | 198 | 2 | cv:CN043612 | |
| Disease | Situs Inversus | 2.37e-03 | 11 | 198 | 2 | C0037221 | |
| Disease | cup-to-disc ratio measurement | 2.61e-03 | 430 | 198 | 9 | EFO_0006939 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Gastrointestinal Diseases | 2.83e-03 | 12 | 198 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 2.83e-03 | 12 | 198 | 2 | C0559031 | |
| Disease | Cholera Infantum | 2.83e-03 | 12 | 198 | 2 | C1565321 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | urate measurement | USP34 STC1 BMPR2 PAX8 MYO18B CNTN2 RPS6KA4 SHMT2 VARS2 DNAH1 PPP2R1B MALRD1 UNC5CL AKAP13 | 3.02e-03 | 895 | 198 | 14 | EFO_0004531 |
| Disease | biliary liver cirrhosis | 3.22e-03 | 44 | 198 | 3 | EFO_0004267 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.30e-03 | 148 | 198 | 5 | C0279702 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.33e-03 | 13 | 198 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 3.33e-03 | 13 | 198 | 2 | cv:C4273714 | |
| Disease | colitis (implicated_via_orthology) | 3.33e-03 | 13 | 198 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | colon carcinoma (is_marker_for) | 3.33e-03 | 13 | 198 | 2 | DOID:1520 (is_marker_for) | |
| Disease | neuroticism measurement | MYH2 MED24 TAOK3 FAM120A NTN1 HOOK2 THSD7A RASSF10 MON1B CBFA2T3 CRB1 KANSL1 CTNNA3 LTBP3 | 3.46e-03 | 909 | 198 | 14 | EFO_0007660 |
| Disease | Degenerative polyarthritis | 3.61e-03 | 93 | 198 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 3.61e-03 | 93 | 198 | 4 | C0086743 | |
| Disease | Seizures | 3.64e-03 | 218 | 198 | 6 | C0036572 | |
| Disease | alkaline phosphatase measurement | USP34 VWDE MED24 MYO3A ADSL ARHGAP10 RBL2 ADAMTS13 KANSL1 CCM2L RNF146 CDYL2 MACF1 AKAP13 LTBP3 | 3.68e-03 | 1015 | 198 | 15 | EFO_0004533 |
| Disease | waist-hip ratio | NAB1 DGKQ STC1 ADAMTS9 ADAMTS20 CNTN2 COL6A2 RBL2 RASSF10 ADAMTS10 PPP2R1B P4HTM RNF146 CDYL2 LTBP3 ATP1B2 CCDC171 | 3.87e-03 | 1226 | 198 | 17 | EFO_0004343 |
| Disease | systemic lupus erythematosus (is_marker_for) | 3.88e-03 | 47 | 198 | 3 | DOID:9074 (is_marker_for) | |
| Disease | Primary Ciliary Dyskinesia | 3.88e-03 | 47 | 198 | 3 | C4551720 | |
| Disease | Paroxysmal atrial fibrillation | 4.12e-03 | 156 | 198 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.12e-03 | 156 | 198 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.12e-03 | 156 | 198 | 5 | C2585653 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.37e-03 | 49 | 198 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.44e-03 | 15 | 198 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Hepatitis | 4.44e-03 | 15 | 198 | 2 | C0019158 | |
| Disease | Atrial Fibrillation | 4.59e-03 | 160 | 198 | 5 | C0004238 | |
| Disease | Adenoid Cystic Carcinoma | 4.67e-03 | 100 | 198 | 4 | C0010606 | |
| Disease | Pancreatic Neoplasm | 4.67e-03 | 100 | 198 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 5.01e-03 | 102 | 198 | 4 | C0346647 | |
| Disease | white matter microstructure measurement | 5.02e-03 | 390 | 198 | 8 | EFO_0005674 | |
| Disease | body weight | EFEMP1 ADSL PAX8 SPOCK3 ANLN PPFIA3 MON1B CRB1 CCND3 TGFB2 ADAMTS10 CTNNA3 SENP6 LTBP3 CCDC171 NEK11 TPBG | 5.10e-03 | 1261 | 198 | 17 | EFO_0004338 |
| Disease | neuroticism measurement, cognitive function measurement | ADCY2 SYNGAP1 MED24 FAM120A THSD7A RBL2 RASSF10 PCDHA10 KIAA0825 NAGPA | 5.12e-03 | 566 | 198 | 10 | EFO_0007660, EFO_0008354 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.45e-03 | 53 | 198 | 3 | C4707243 | |
| Disease | Muscle hypotonia | 5.70e-03 | 17 | 198 | 2 | C0026827 | |
| Disease | MHPG measurement, 5-HIAA measurement | 5.70e-03 | 17 | 198 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Pneumonia | 5.74e-03 | 54 | 198 | 3 | C0032285 | |
| Disease | hair morphology measurement | 5.74e-03 | 54 | 198 | 3 | EFO_0007821 | |
| Disease | Lobar Pneumonia | 5.74e-03 | 54 | 198 | 3 | C0032300 | |
| Disease | Small cell carcinoma of lung | 5.74e-03 | 54 | 198 | 3 | C0149925 | |
| Disease | Pneumonitis | 5.74e-03 | 54 | 198 | 3 | C3714636 | |
| Disease | Experimental Lung Inflammation | 5.74e-03 | 54 | 198 | 3 | C0887898 | |
| Disease | empathy measurement | 5.91e-03 | 170 | 198 | 5 | EFO_0009183 | |
| Disease | triacylglycerol 52:2 measurement | 6.04e-03 | 55 | 198 | 3 | EFO_0010414 | |
| Disease | optic cup area measurement | 6.35e-03 | 56 | 198 | 3 | EFO_0006940 | |
| Disease | response to platinum based chemotherapy | 6.39e-03 | 18 | 198 | 2 | EFO_0004647 | |
| Disease | kidney volume | 6.39e-03 | 18 | 198 | 2 | EFO_0600044 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SACEEENERLTESLR | 26 | O15155 | |
| SDEQDSVRLLAVEAC | 226 | P30154 | |
| RAALSEERSCREELG | 171 | Q96MC4 | |
| LEAEEERTRLCDDRL | 751 | Q9P281 | |
| DNEEDRLCRSRQIYD | 96 | P35626 | |
| DEACLIEILASRSNE | 291 | P50995 | |
| RACQEQIEAALRESL | 241 | P30281 | |
| DLDALDVCGRTEIRN | 226 | Q9UL15 | |
| LLSCTQALDDDLQRE | 841 | O94812 | |
| ATLEDLDRLVACSRA | 571 | P56945 | |
| ESACEELNNALLREE | 1036 | Q6TFL3 | |
| CDDDIDGDRIRNQAD | 371 | P49747 | |
| EAERLSQRQTERDLC | 2671 | Q12802 | |
| RANQDLALLCEVRDS | 446 | Q9BR77 | |
| AVVLDVACFAEAERL | 541 | P52824 | |
| LVSCENDILRDDSLL | 341 | Q5VUY2 | |
| GDLREERVSFLCAND | 91 | Q4G176 | |
| AQLDLCEDEDVSIRR | 66 | Q9BZZ5 | |
| DDRTSCIVRQALERE | 511 | Q9ULJ7 | |
| RELEAASACLDEARA | 806 | Q8TF21 | |
| ACEEARQGLAELREA | 891 | Q8TF21 | |
| RELCSLRFSLNQEEE | 786 | Q9UPS8 | |
| LAVANRDAAEESCAL | 306 | Q9NUG4 | |
| DCERVARLEEENSSL | 196 | Q9HA90 | |
| ERERSCSVNEDIGLA | 371 | Q9H324 | |
| CQRRVSAAEEKALDD | 911 | Q9H324 | |
| QDVEVDEAACAALVR | 1046 | Q76LX8 | |
| LADNECQELSRVTRE | 1001 | P59510 | |
| VLDALDRSIIDCRAE | 31 | C9JTQ0 | |
| IQDDVDLRDTRRHCD | 391 | Q9NXG6 | |
| AARCVRDRDDSLVCD | 291 | O95631 | |
| AAALEELARRCDDLL | 316 | A6NK89 | |
| REKRAAALEACLDVT | 161 | Q9H0G5 | |
| EIRDRLLAEGVCDND | 106 | Q06710 | |
| TANRIDREELCAQSA | 86 | Q9Y5H1 | |
| SVRQAFERLVDAICD | 171 | P20337 | |
| EEQEALCLDLRGTER | 1381 | A6NNM3 | |
| EEQEALCLDLRGTER | 1381 | A6NJZ7 | |
| ELLCQRRALEAFDLD | 116 | P34897 | |
| TAAQERNVLAECRLD | 286 | Q7L1V2 | |
| ELCSRLNMDEAARAE | 51 | Q08999 | |
| EAAETLEECALRSRR | 481 | Q9NSK0 | |
| DTEACRATLNLEERR | 81 | Q6IE37 | |
| VTDDERCIDASLREF | 76 | A1A4S6 | |
| RDLEVVEGSAARFDC | 1816 | Q15746 | |
| LVEVARRCRDEAIAA | 206 | Q6UB28 | |
| QEAARARELELEACS | 496 | Q9BRK4 | |
| ARELELEACSQELQR | 501 | Q9BRK4 | |
| ALACRDDSFQEIRAN | 501 | Q8IV33 | |
| LTDEEDCARLQQAAS | 26 | Q92886 | |
| SVRFEEDEDRNLCLI | 71 | Q9UHH9 | |
| EERRQCAEDLLQFSA | 96 | Q96S38 | |
| LDAAAALSVAECVER | 191 | Q13506 | |
| SSDEAARLVRELCEQ | 141 | Q5JR98 | |
| ESGREDERLRCAELE | 256 | Q96ED9 | |
| RDSLREANEELRCAQ | 411 | Q96ED9 | |
| AELEEALERQRAEVC | 236 | O75145 | |
| EDDRETLVSQCRDTL | 1066 | Q9NQW6 | |
| CRINAANIATDDERD | 261 | P14415 | |
| VQIERLDAVESLCAD | 416 | Q9UNE0 | |
| ELCSRLEREAARLAD | 651 | Q8NFR9 | |
| ADQAALAARQECDIA | 391 | Q9HDC5 | |
| CVRSLDVLVLDEADR | 161 | Q8NHQ9 | |
| GEACAAREAALRERL | 171 | A0A1B0GVG4 | |
| EQLRAEAELCAEAEE | 911 | Q7Z406 | |
| EAELCAEAEETRGRL | 916 | Q7Z406 | |
| ELERACRVAEQAAND | 1546 | Q7Z406 | |
| LDEVDRLANRTRDAC | 326 | O43157 | |
| AGRIDREELCAQSAR | 91 | Q9Y5H3 | |
| ERLLTAEAFADCQDL | 226 | Q02817 | |
| AEGLADAEERCDQLI | 901 | Q9UKX2 | |
| CERRNHIDRALDATE | 286 | P25025 | |
| ELRRLEEEACRAAQE | 926 | Q9HD67 | |
| EEEACRAAQEFLESL | 931 | Q9HD67 | |
| DSDIEALARCLENVL | 521 | Q8NG66 | |
| EDQLDAQERAARCTR | 1051 | Q7Z3B3 | |
| LDELTLCRSDLEAQV | 166 | O76009 | |
| ATLNRADADLEACRT | 386 | Q86UK5 | |
| DTEAALQCLREAAER | 226 | Q9P2M1 | |
| DDATCRLFDLRADQE | 246 | P62879 | |
| DDASCRLFDLRADQE | 246 | P16520 | |
| DDATCRLFDLRADQE | 246 | Q9HAV0 | |
| DDATAREEADLRFCQ | 476 | Q96N16 | |
| DDESCAVELRITEAN | 6 | O75676 | |
| DRVRLESELCSLQAA | 186 | Q9NSB4 | |
| AETELCAEAEELRAR | 891 | P35579 | |
| SACRREAALEAAVLN | 1101 | Q9NZB2 | |
| ARLCAEAERKAAEAA | 86 | B2RBV5 | |
| AETACFREERDVLVN | 116 | Q9Y5S2 | |
| CDFGLARVEELDESR | 281 | Q9UBE8 | |
| SLTVLRRCQEADREE | 416 | O75081 | |
| RAVLLASDAQECTLE | 321 | Q27J81 | |
| REAAVLQEIRDHCAE | 186 | Q6NXR0 | |
| DCAEVDAILREISER | 276 | D6RGH6 | |
| DAILREISERCDEAL | 281 | D6RGH6 | |
| SVADRLRLEEEVEAC | 1011 | Q9UPN3 | |
| IDEVESLTAARNACR | 251 | Q15645 | |
| NSRIDREELCGRSVE | 86 | Q9Y5I2 | |
| VLSADDIAAALQECR | 6 | P0CE72 | |
| DTDLCRFDATDEELR | 251 | Q5VYJ5 | |
| ALSEENESRRRCADA | 96 | P78367 | |
| LFDQFRRDCLADVDT | 66 | Q8NFC6 | |
| RRSCIDESQISAEEA | 116 | Q15884 | |
| CIIALRDQDADNLDR | 521 | Q9UI47 | |
| ACQEVALDIRARIEE | 1076 | Q9P2D7 | |
| ILDEAIREACRNSNL | 1821 | Q9P2D7 | |
| ADQRLSSDCEDQIRI | 976 | Q92896 | |
| ECLRLLNEIIADFDD | 911 | Q08462 | |
| ARSCIEDRLRLEDEN | 246 | Q08828 | |
| RAICVNTRNDVLDDS | 1021 | Q9P2N4 | |
| ALVRECLAETERNAR | 111 | O75956 | |
| ELELARNDIDLCQSD | 1036 | Q14674 | |
| ARNIAVCVEFRDSDE | 661 | Q5JSL3 | |
| DDATCRLFDLRADQE | 246 | P62873 | |
| ARAECSNADLELLVR | 596 | H7BZ55 | |
| SRLIAAERERELEEC | 166 | Q9UNE7 | |
| LCLLAADEDDDRDVA | 56 | P24522 | |
| ATVAACDLDRAAAQE | 36 | Q92506 | |
| CDLDRAAAQETVRLL | 41 | Q92506 | |
| DLNLRALCDRDVTVT | 741 | P12110 | |
| EVNTRLCDEFERIAE | 581 | Q8WXX0 | |
| EDVLIRASACLEEAA | 176 | Q8N4Y2 | |
| RASACLEEAARERDG | 181 | Q8N4Y2 | |
| QDAEARLTAQCAEER | 486 | Q13873 | |
| QEEEERGECLARSAS | 66 | Q02410 | |
| ACDQGDTETARRLLE | 16 | Q68DC2 | |
| ESTEEQVLLACRARA | 51 | Q02246 | |
| SRDEECDRIISGIDQ | 1161 | Q9NSI6 | |
| DASRARCVDIDECRE | 1246 | Q9NS15 | |
| SCLLEQDRAREDLQA | 541 | Q6ZW76 | |
| EQFARLEDCVLLATD | 631 | Q9GZR7 | |
| LISRDDLNVRCESEV | 231 | Q14145 | |
| DIARLRDDLLDCQAQ | 741 | Q9NT22 | |
| RCEVDLADDLISDIF | 1331 | P82279 | |
| SRDLQEERLSAVCIA | 21 | Q8IX18 | |
| CELRAELERLQAENT | 346 | Q68D86 | |
| DERASQRCLRQAEEL | 741 | Q9UPN4 | |
| LEACQREAAAAREEA | 116 | Q494R4 | |
| EDACEDDSRLQLAQT | 391 | Q6PJW8 | |
| DGCEELERLRAALQS | 156 | Q8WZA9 | |
| DALVALEEDQCLRQA | 461 | Q5TDP6 | |
| SSDRLNCEDIDECRT | 286 | Q12805 | |
| DLTCNITTDRADDVR | 296 | Q9P2B2 | |
| ELRDAFERDSAAVCL | 446 | Q6ZW31 | |
| LVSDLCARVRDADTN | 16 | Q9BQG1 | |
| CALRSAISDIEVENR | 281 | Q5ST30 | |
| VDADDVRLAIQCRAD | 66 | Q9HBM6 | |
| VDADDVRLAIQCRAD | 66 | Q16594 | |
| DREAKLAENACTLAD | 306 | P05423 | |
| ACKLFRDDERALAQE | 41 | Q12872 | |
| VARSLLDTLREVCDD | 66 | Q8TF05 | |
| QDFELLCRDGSRADV | 251 | P08582 | |
| GAERLDALLADEERC | 121 | Q15628 | |
| SDGEEVDRQLCRDAI | 606 | Q9UPZ6 | |
| ENCGEDALREAERFV | 256 | Q8WXG1 | |
| TFDDLLNRLEDLVCD | 346 | O43776 | |
| FLASVEECRTELDRE | 1031 | Q8NF91 | |
| ETRLCAQEAEALRRE | 226 | O15061 | |
| EARDVEVARCGALAL | 601 | Q5T2S8 | |
| LDDSANRRICLAEAF | 331 | P30566 | |
| DDFSRDLCVQALLDI | 86 | O75448 | |
| ATVEETARAADCRVA | 121 | Q9UK23 | |
| EDRLAACARECVESL | 236 | O43147 | |
| LLSSVDNCAEDIREI | 921 | Q9P2F8 | |
| LRLDCDANTVNLARE | 181 | Q9NTX7 | |
| DTSEDLRLQCDAVNL | 276 | Q8WW24 | |
| ASQALRLDEAQEAEC | 781 | Q9H2K8 | |
| RLDEAQEAECQALRL | 786 | Q9H2K8 | |
| RQALAACEELADRST | 741 | Q8TF17 | |
| ACEELADRSTQRALC | 746 | Q8TF17 | |
| QAEADALADAEERCD | 896 | Q9Y623 | |
| REDAAVARDLDCSLE | 81 | Q92966 | |
| VARDLDCSLEAAAEL | 86 | Q92966 | |
| LEQALCRAEDEEDIR | 2241 | Q6ZRS2 | |
| CRAEDEEDIRAATQA | 2246 | Q6ZRS2 | |
| RAETACFREERDVLV | 116 | Q5VT25 | |
| AANRVEICRDQLSAD | 186 | Q17R89 | |
| DDARAARVKELLVDC | 106 | Q96C90 | |
| RSAECIDEAAERLGA | 26 | Q8IYS1 | |
| AEELERLCESNRVDA | 166 | Q9UHB9 | |
| NRLVRSLLECDEDTV | 161 | P52823 | |
| LCDLSRFQEAELLVD | 636 | Q9Y5Q9 | |
| FVVDCADRDRIDEAR | 86 | P62330 | |
| LDNADVALACARVLD | 56 | E9PGG2 | |
| KEVRRALCNAATDDS | 281 | Q8N8U2 | |
| LDERCAIINFRSSEE | 176 | Q8WTT0 | |
| VLERCDLELETNGRD | 6 | P21980 | |
| DLLQEKASRRAAACE | 76 | P61812 | |
| AEGERARAASDVLCR | 131 | Q8NFZ5 | |
| ARAASDVLCRSLANE | 136 | Q8NFZ5 | |
| LCSDEDAQELLRESQ | 696 | Q9Y4G8 | |
| LIRAADDREEDGCSQ | 1026 | Q9UNS1 | |
| RLNDDCDAETRVTIE | 1161 | Q8N2E2 | |
| EESSRDQELAAVLEC | 176 | Q96SZ4 | |
| LRAEERFCDVTIVAD | 26 | Q9Y330 | |
| DCIRAIAANEADAVT | 66 | P02787 | |
| LLTAARDAEEALRCL | 411 | Q5JTV8 | |
| RDAEEALRCLSEQIA | 416 | Q5JTV8 | |
| READDARLSVSLCDL | 241 | O76050 | |
| EDVEVLEGRAARFDC | 1071 | Q15772 | |
| CAERGREDIADRLIS | 576 | Q96PV0 | |
| CDFVRSRLEVTDDLE | 251 | P35813 | |
| NLAAVEICRDASRET | 96 | Q9HAI6 | |
| EEAAREDCLQGIRSF | 176 | Q96QS1 | |
| SLRNDRAEACEREGF | 316 | Q70CQ1 | |
| FRRKAADENEDCSAL | 346 | Q8IV45 | |
| NDFEDIRSEDCILSL | 241 | Q7Z5K2 | |
| INLRRSIEEALCSEA | 726 | C9JH25 | |
| ALVCDNVEDARRIAF | 616 | Q14683 | |
| EAALNENTCRAEREL | 371 | Q9GZR1 | |
| RNDLTEVERELCSAT | 526 | Q14997 | |
| CSDLEFREVANRLRD | 201 | Q9BQ16 | |
| LQQCEERLDSELTAR | 1536 | Q8IUG5 | |
| AQDCREELARRVADV | 236 | Q9NXH8 | |
| AALCSDEAERLTRLN | 21 | Q9Y2L5 | |
| NRVLLELNSADLDCD | 331 | Q13641 | |
| ADCIRSREILDHQDG | 1766 | Q70CQ2 | |
| SEDDLNRLDSVACDV | 941 | Q5T4S7 | |
| AAGAECELAREQRDA | 691 | Q9C0B0 | |
| RERALLCFLDQLEDE | 1131 | Q6ZS17 | |
| IKARNIRLSEAACED | 226 | O95801 | |
| SDHEIDRLELQNGRC | 381 | P19438 | |
| LECESLTERREDFQD | 441 | O94782 | |
| SCSLVIRDAQREDEA | 101 | A6NMB1 | |
| DRLARLVDTDTVLDC | 2796 | Q9Y493 | |
| RDISNDAVDICNEAA | 166 | Q8N402 | |
| LRVELAEEDDCSNSS | 411 | Q9BYP7 | |
| AVAEEERCTVERRAD | 36 | Q96S16 | |
| ASLLCIRADELQEAL | 636 | Q8NEV4 |